t 817

Edonerpic maleate (T-817 maleate) is a neurotrophic agent which can inhibit amyloid-β peptides (Aβ).

Glycyl-glutamine (Glycyl-L-glutamine monohydrate) is an inhibitory neuropeptide derived from beta-endorphin.

2-O-α-D-Glucopyranosyl-L-ascorbic Acid (ASCORBYL GLUCOSIDE), a glucoside derivative of ascorbic acid, exhibits anti-cancer properties upon enzymatic conversion to ascorbic acid.

Delafloxacin meglumine (RX-3341 meglumine) is a broad-spectrum fluoroquinolone antibiotic.

Carboxyatractyloside (Carboxyatractyloside tripotassium salt) is a natural product. It acts as an inhibitor of ADP/ATP carrier, inhibits mitochondrial ADP/ATP transport.

Nardoguaianone K, a guaiane-type sesquiterpenoid isolated from the roots of Nardostachys chinensis, has potential applications in pancreatic cancer research [1] [2].

Narciclasine-4-O-β-D-glucopyranoside, a compound with anticancer activity [1], can be isolated from Pancratium maritimum.

Naratuximab (Anti-TSPAN26/CD37 Reference Antibody) is a humanized monoclonal antibody against CD37 that can be used to synthesize the ADC compound Naratuximab emtansine.

Naptumomab (ABR-217620) is a tumor-targeted superantigen (TTS) fusion protein consisting of a Fab fragment targeting the 5T4 oncofetal antigen and a modified staphylococcal enterotoxin A (SEA/E-120). This product specifically recognizes 5T4 protein expressed on various solid tumors via the Fab fragment and potently activates T cells (primarily by binding to the TCR Vβ chain) through the superantigen component, inducing T cell-mediated cytotoxicity against tumor cells. It bypasses major histocompatibility complex (MHC) restriction to directly recruit and activate a large number of effector T cells into the tumor microenvironment.

Nangibotide, a TREM-1 receptor inhibitor, modulates the innate immune response and has demonstrated the potential to reduce systemic and localized inflammatory reactions in rodent models of myocardial ischemia-reperfusion [1].

Nagrestipen, a variant of the human macrophage inflammatory protein-1 alpha (MIP-1α), also referred to as ECI 301, exhibits antitumor activity. It is employed in therapeutic trials focused on cancer, assessing its efficacy in the contexts of tumors, metastasis, radiation oncology, and the analysis of tumor metastasis [1].

N-Acetyldopamine dimer-3 (Compound 11), a naturally occurring chemical, is present in the species Aspongopus chinensis [1].

Naa50-IN-1 (Compound 4a) is a potent inhibitor of N-α-Acetyltransferase 50 (Naa50), demonstrating an IC50 of 7 mM, with potential applications in cancer research [1].

N-4′-(p-Trifluoromethylphenyl)butyl-DAB (compound 5g) acts as an agonist for lysosomal acid α-glucosidase (GAA), dose-dependently enhancing intracellular GAA activities in Pompe disease patient fibroblasts harboring the M519V mutation [1].

N3-PEG8-Phe-Lys-PABC-Gefitinib is an antibody-drug conjugate (ADC) agent-linker complex exhibiting potent antitumor activity. It incorporates the orally active EGFR tyrosine kinase inhibitor Gefitinib, tethered by the cleavable linker N3-PEG8-Phe-Lys-PABC. As a click chemistry reagent, it features an azide group facilitating copper-catalyzed azide-alkyne cycloaddition (CuAAC) with alkyne-bearing molecules. Additionally, it can engage in strain-promoted alkyne-azide cycloaddition (SPAAC) with compounds presenting DBCO or BCN groups.

N3-PEG3-VC-PAB-MMAF (Comp T-88-5) is a drug-linker conjugate for antibody-drug conjugates (ADCs) comprising the ADC linker N3-PEG3-VC-PAB and the microtubule-disrupting agent MMAF [1]. This click chemistry reagent features an azide group for copper-catalyzed azide-alkyne cycloaddition (CuAAC) with alkyne-bearing molecules and can also perform strain-promoted alkyne-azide cycloaddition (SPAAC) with compounds presenting DBCO or BCN groups.

N36 peptide, an (HIV-1 gp41 fusion peptide), exhibits biological activity.

N-[(6S)-6-Carboxy-6-(glycylamino)hexanoyl]-D-alanyl-D-alanine inhibits the PAICS protein, reducing the accumulation of SAICAR and SAICAr.

N,N'-Dinitrosopiperazine (1,4-Dinitrosopiperazine, DNP) is a known carcinogen associated with the development and metastasis of nasopharyngeal carcinoma. Its carcinogenic mechanism involves multiple signaling pathways, particularly exerting effects through the regulation of phosphorylation at the Ser568 site of the LYRIC protein. It can be used to induce esophageal cancer models.

N,N-Dimethyldoxorubicin, a Doxorubicin analogue, exhibits cytotoxicity against a range of tumor cell lines with IC50 values below 0.3 μM [1].

N-(3-Oxodecanoyl)-L-homoserine lactone (3-Oxo-C10-HSL) serves as a crucial bacterial signaling molecule, acting as an autoinducer in quorum sensing. It regulates bacterial gene expression, virulence factor production, biofilm formation, and synchronized group behavior in a concentration-dependent manner. This makes it a key molecular tool for studying bacterial communication mechanisms, pathogen virulence regulation, and screening anti-infection targets.

N-(2-Hydroxyphenyl)picolinamide exhibits inhibitory activity against histone deacetylase 1, 2, and 3, with IC₅₀ values of 12.43, 4.106, and 3.623 μM, respectively, and can be used in related research in the life sciences.

Mz325 is an effective dual inhibitor of HDAC6 and SIRT2, with IC50 values of 0.043 μM and 0.32 μM respectively, and can be used for the study of tubulin deacetylation.

Unfortunately, you did not provide the description of the chemical compound that needs to be rewritten. Please provide the text, so I can assist you in improving its clarity and conciseness.